| Pfizer AG - Zavedos 5 mg, Hartkapseln | | 52256 | | 01 | | Zavedos 5 mg | | Hartkapseln | | L01DB06 | | Idarubicin | | 29.08.1997 | | |
| | Composition | | idarubicini hydrochloridum 5 mg, cellulosum microcristallinum, glyceroli palmitostearas, gelatina, E 171, E 172 (rubrum), lacca, propylenglycolum, ammoniae solutio 30 per centum, E 172 (nigrum), kalii hydroxidum, pro capsula. | | Packungsbestandteile | | Capsules | | | | Active Agent | Dose |
|---|
| Idarubicin Hydrochloride | 5 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Nigrum) | | | | (Rubrum) | | | | Ammoniae Solutio | 30 | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Gelatina | | | | Glyceroli Palmitostearas | | | | Kalii Hydroxidum | | | | Lacca | | | | Per Centum | | | | Pro Capsula | | | | Propylenglycol | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 011 | Capsule(s) | 49.87 | 73.65 | A | | Yes |
|
|
